Incyte Corp at Cowen Health Care Conference Transcript
Healthcare Conference. I'm Marc Frahm, the biotech team. Next up, we're really pleased to have with us CFO from Incyte , Christiana Stamoulis; and the General Manager of North America, Barry Flannelly.
Questions & Answers
So maybe to start off, Christiana, you want to just kind of level set people on, insight status updates and kind of what are the major updates you're looking to over the next 6, 12 months?
Sure. So as you may recall from our earnings call this last month, we had progress along a number of different fronts in 2022 that we are looking to continue in '23. First, on the commercial end, very important was the progress of the Opzelura launch both in AD as well as in vitiligo, which was the indication that we got approval for in 2022.
We are very much looking forward
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
